Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Replimune Group Inc buy Barclays PLC

Start price
€7.15
07.06.24 / 50%
Target price
€15.73
07.06.25
Performance (%)
28.67%
Price
€9.55
26.07.24
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC currently has a performance of 28.67%. This prediction currently runs until 07.06.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Replimune Group Inc 0.526% 0.526%
iShares Core DAX® 0.786% 1.251%
iShares Nasdaq 100 1.855% -2.687%
iShares Nikkei 225® 3.947% 2.199%
iShares S&P 500 1.787% 0.151%

Comments by Barclays_PLC for this prediction

In the thread Replimune Group Inc diskutieren
Prediction Buy
Perf. (%) 28.67%
Target price 15.732
Change
Ends at 07.06.25

Replimune Group, Inc. (NASDAQ: REPL) had its price target raised by analysts at Barclays PLC from $13.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for REPL provided by MarketBeat

Stopped prediction by Barclays_PLC for Replimune Group Inc

buy
Replimune Group Inc

Start price
Target price
Perf. (%)
€6.90
06.12.23
€12.05
06.12.24
33.33%
26.07.24